HIV-positive women may experience menopause at a younger age than their HIV-negative counterparts, according to a study presented at the Fifth...

Once-daily Kaletra (lopinavir/ritonavir) dosing may be an option for treatment-experienced people living with HIV, according to study results...

Chronic stress may increase the risk of non-AIDS, age-related health problems in people living with HIV, according to a team of Spanish resear...

Switching to Norvir-boosted Prezista monotherapy after achieving an undetectable viral load using combination ARV treatment worked well

People whose virus is well controlled by a regimen containing Norvir (ritonavir)-boosted Reyataz (atazanavir) can drop the Norvir—while...

A quadruple combination of four similar drugs from the same class—Truvada (tenofovir plus emtricitabine), Retrovir (zidovudine) and Ziag...

HIV-positive children exposed to single-dose Viramune (nevirapine) at birth are more likely to have virologic success later with a Kaletra (lo...

A daily supplement including key vitamins and minerals showed promise for increasing survival in Ugandan children living with HIV, according t...

There were no HIV transmissions and few birth defects in the babies of HIV-positive African women who were treated with ARV therapy.

Cancer of all types is more likely when a person’s CD4 counts fall below 200; however, even people with CD4 counts up to 699 had a higher risk...